These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8162312)

  • 1. Characterization and quality control of autologous gene transfer therapeutics.
    Jolly DJ
    Cell Transplant; 1994; 3 Suppl 1():S57-60. PubMed ID: 8162312
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic gene therapy and its implications in melanoma treatment.
    Möller P; Schadendorf D
    Arch Dermatol Res; 1997 Jan; 289(2):71-7. PubMed ID: 9049039
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.
    Stewart AK; Lassam NJ; Graham FL; Gauldie J; Addison CL; Bailey DJ; Dessureault S; Dubé ID; Gallenger S; Krajden M; Rotstein LE; Quirt IC; Moen R
    Hum Gene Ther; 1997 Jul; 8(11):1403-14. PubMed ID: 9295135
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative.
    Kent A; King NM; Cohen-Haguenauer O
    Hum Gene Ther; 2011 Feb; 22(2):126-34. PubMed ID: 20942607
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
    Nemunaitis J; Bohart C; Fong T; Meyer W; Edelman G; Paulson RS; Orr D; Jain V; O'Brien J; Kuhn J; Kowal KJ; Burkeholder S; Bruce J; Ognoskie N; Wynne D; Martineau D; Ando D
    Cancer Gene Ther; 1998; 5(5):292-300. PubMed ID: 9824048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma.
    Seigler HF; Darrow TL; Abdel-Wahab Z; Gangavalli R; Barber J
    Hum Gene Ther; 1994 Jun; 5(6):761-77. PubMed ID: 7948138
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of retroviral vector-administered interferon-gamma (IFN-gamma) gene in metastatic melanoma.
    Nemunaitis J; Buchanan A; Jolly DJ
    Cancer Gene Ther; 2000 Oct; 7(10):1297-8. PubMed ID: 11059685
    [No Abstract]   [Full Text] [Related]  

  • 9. As number of trials increases, gene therapy begins to look promising for medicine's future.
    Marwick C
    JAMA; 1992 Jun; 267(21):2854-5. PubMed ID: 1583740
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of molecular genetic interventions for HIV infection.
    Woffendin C; Ranga U; Nabel GJ
    Curr Protoc Hum Genet; 2001 May; Chapter 13():Unit 13.6. PubMed ID: 18428255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of malignant melanoma with gene therapy.
    Hersh EM; Stopeck AT
    Mol Med; 1997 Oct; 3(10):636-51. PubMed ID: 9392001
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 7 trials for melanoma treatment.
    Schadendorf D; Henz BM; Wittig B
    Mol Med Today; 1996 Apr; 2(4):144-5. PubMed ID: 8829827
    [No Abstract]   [Full Text] [Related]  

  • 13. Scope and limitations of gene therapy for HIV infection.
    Bowers M; Chang HE
    BETA; 1996 Mar; ():37-8. PubMed ID: 11363316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular immunization or immunotherapy for HIV infection?
    Featherstone C
    Mol Med Today; 1996 Jul; 2(7):271. PubMed ID: 8796904
    [No Abstract]   [Full Text] [Related]  

  • 15. The current status of gene therapy in autologous transplantation.
    Becker PS
    Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid DNA for human gene therapy and DNA vaccines. Production and quality assurance.
    Schorr J; Moritz P; Seddon T; Schleef M
    Ann N Y Acad Sci; 1995 Nov; 772():271-3. PubMed ID: 8546406
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy.
    Marasco WA; Chen S; Richardson JH; Ramstedt U; Jones SD
    Hum Gene Ther; 1998 Jul; 9(11):1627-42. PubMed ID: 9694161
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
    Khorana AA; Rosenblatt JD; Sahasrabudhe DM; Evans T; Ladrigan M; Marquis D; Rosell K; Whiteside T; Phillippe S; Acres B; Slos P; Squiban P; Ross M; Kendra K
    Cancer Gene Ther; 2003 Apr; 10(4):251-9. PubMed ID: 12679797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.